Ligand Pharmaceuticals, Inc. (LGND)
223.42
-1.74
(-0.77%)
USD |
NASDAQ |
Apr 16, 16:00
223.42
0.00 (0.00%)
After-Hours: 18:44
Ligand Pharmaceuticals Research and Development Expense (Quarterly) : 3.511M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 23.74M |
| ADMA Biologics, Inc. | 1.376M |
| Intuitive Surgical, Inc. | 352.90M |
| Johnson & Johnson | 4.268B |
| Establishment Labs Holdings, Inc. | 5.434M |